The epidemiology of hepatitis C virus in the maghreb region: Systematic review and Meta-analyses

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Fadlalla, Fatima A ^a,b   Mohamoud, Yousra A ^a   Mumtaz, Ghina R ^a   Abu Raddad, Laith J ^a,c,d  

^a Department of Obstetrics Gynecology   (Qatar)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; DENTAL PROCEDURE; DRUG ABUSE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTERMEDIATE RISK POPULATION; MIDDLE EAST; NONHUMAN; NORTH AFRICA; PREVALENCE; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; SURGERY; SYSTEMATIC REVIEW; AFRICA; BLOOD; HEPACIVIRUS; IMMUNOLOGY; META ANALYSIS; STATISTICAL MODEL;

HEPATITIS C VIRUS;

VIRUS ANTIBODY;

AFRICA, NORTHERN; ANTIBODIES, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; MODELS, STATISTICAL; PREVALENCE;

EID: 84925880266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121873     Document Type: Review

References (89)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57 (4):1333-42. Epub 2012/11/23. doi: 10.1002/hep.26141 PMID: 23172780.
2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011; 17 (2):107-15. Epub 2010/11/26. doi: 10.1111/j.1469-0691.2010.03432.x PMID: 21091831.
3. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Egyptian: Ministry of Health. Cairo: El-Zanaty and Associates, and Macro International; 2009.
4. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC infectious diseases. 2013; 13:288. Epub 2013/06/27. doi: 10.1186/1471-2334-13-288 PMID: 23799878; PubMed Central PMCID: PMC3702438.
5. United Nations. United Nations, Department of Economic and Social Affairs Population Division, Populationa Estimates and Projections Section 2010 [cited 7/11/2012]. Available from: http://esa.un. org/unpd/wpp/unpp/panel-population.htm.
6. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. International journal of surgery (London, England). 2010; 8(5):336-41. Epub 2010/02/23. doi: 10.1016/j.ijsu.2010.02.007 PMID: 20171303.
7. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC: The World Bank Press; 2010.
8. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS. 2010; 24 Suppl 2:S5-23. Epub 2010/07/17. doi: 10. 1097/01.aids.0000386729.56683.33 PMID: 20610949.
9. Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC research notes. 2012; 5:52. Epub 2012/01/24. doi: 10.1186/1756-0500-5-52 PMID: 22264277; PubMed Central PMCID: PMC3296675.
10. Freeman MF, Tukey JW. Transformations Related to the Angular and the Square Root. Ann Math Statist. 1950; 21(4):607-11.
11. Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. American Statistician. 1978; 32(4):138.
12. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003; 327:557-60. PMID: 12958120
13. Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC infectious diseases. 2014; 14:17. Epub 2014/01/11. doi: 10. 1186/1471-2334-14-17 PMID: 24405790; PubMed Central PMCID: PMC3893419.
14. Saidane N, Saidi M, Derdous C, Rouabhia S, Soltani F, Ouarhlent Y. Various complications in haemophiliacs managed by Hospital University of Batna, Algeria. Journal of Thrombosis and Haemostasis. 2011; 9:923. doi: http://dx.doi.org/10.1111/j.1538-7836.2011.04380-4.x PMID: 70615197.
15. Aidaoui M. , BouzbidS., LaouarM. Seroprevalence of HIV infection in pregnant women in the Annaba region (Algeria). [French]Seroprevalence de l'infection VIH chez les femmes enceintes dans la regionde Annaba (Algerie). Revue d'Epidemiologie et de Sante Publique. 2008; 56(4):261-6. doi: http://dx.doi.org/10.1016/j.respe.2008.05.023 PMID: 2008518252
16. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. [French]Prevalence des marqueurs seriques des virus des hepatites B et C chez les donneurs de sang et les femmes enceintes en Algerie. Bulletin de la Societe de pathologie exotique (1990). 1995; 88(5):225-8. PMID: 8646011.
17. Mirzoyan L, Berendes S, Jeffery C, Thomson J, Othman HB, Danon L, et al. New evidence on the HIV epidemic in Libya: Why countries must implement prevention programs among people who inject drugs. Journal of Acquired Immune Deficiency Syndromes. 2013; 62(5):577-83. doi: http://dx.doi.org/ 10.1097/QAI.0b013e318284714a PMID: 2013249540.
18. Yerly S, Quadri R, Negro F, Barbe KP, Cheseaux JJ, Burgisser P, et al. Nosocomial outbreak of multiple bloodborne viral infections. The Journal of infectious diseases. 2001; 184(3):369-72. Epub 2001/ 07/10. doi: 10.1086/322036 PMID: 11443566.
19. El-Zouki AY, Bendard AB, Sharif MS. HCV in hemodialysis patients in Benghazi, Libya. Annals of Saudi medicine. 1993; 13(2):203. Epub 1993/03/01. PMID: 17590656.
20. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infectious Diseases. 2012; 12(265). doi: http://dx.doi.org/ 10.1186/1471-2334-12-265 PMID: 2012700411.
21. Elzouki AN, Bushala M, Tobji RS, Khfaifi M. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 1995; 10(4):475-6. Epub 1995/01/01. PMID: 7542751.
22. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi medical journal. 2002; 23 (11):1356-60. Epub 2002/12/31. PMID: 12506296.
23. Kutrani H, El-Gatit A, Shekhteryea A, El-Gitait Y, Sudani O, Akoub S. Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab Jamahiriya. [Arabic]. Eastern Mediterranean Health Journal. 2007; 13(1):85-97. PMID: 2007396465.
24. Alashek W, McIntyre C, Taal M. Morbidity of diabetic end-stage kidney disease patients treated by dialysis in Libya. Diabetes, Obesity and Metabolism. 2010; 12:76-7. doi: http://dx.doi.org/10.1111/j. 1463-1326.2010.01284.x PMID: 70569581.
25. Ziglam H, Zorgani AA, Balouz A, Abudhe AH, Elahmer O. Prevalence of antibodies to human immunodeficiency virus, hepatitis B, and hepatitis C in prisoners in Libya. Libyan Journal of Medicine. 2012; 7 (1). PMID: 2012750436.
26. Valadez JJ, Berendes S, Jeffery C, Thomson J, Ben Othman H, Danon L, et al. Filling the Knowledge Gap: Measuring HIV Prevalence and Risk Factors among Men Who Have Sex with Men and Female Sex Workers in Tripoli, Libya. PLoS ONE. 2013; 8(6). doi: http://dx.doi.org/10.1371/journal.pone. 0066701 PMID: 2013391009.
27. Saleh MG, Pereira LM, Tibbs CJ, Ziu M, al-Fituri MO, Williams R, et al. High prevalence of hepatitis C virus in the normal Libyan population. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994; 88(3):292-4. Epub 1994/05/01. PMID: 7974663.
28. Abddulsalam Bagar S, Abdallah B, Neferro F. Prevalence of hepatitis C virus among patients attending a hospital in Sirte, Libya. Clinical Microbiology and Infection. 2010; 16:S311. doi: http://dx.doi.org/ 10.1111/j.1469-0691.2010.03239.x PMID: 70195733.
29. Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. The Journal of hospital infection. 2009; 72 (3):258-61. Epub 2009/05/16. doi: 10.1016/j.jhin.2009.03.019 PMID: 19443080.
30. Shabash A, Habas M, Fara A, Daw M. Epidemiological analysis of potential risk factors contributing to infection of HBV, HCV and HIV among the population in Tripoli Area, Libya. Clinical Microbiology and Infection. 2010; 16:S309. doi: http://dx.doi.org/10.1111/j.1469-0691.2010.03239.x PMID: 70195728.
31. Shabash A, Habas M, Alhajrasi A, Furarah A, Bouzedi A, Daw M. Forecast modelling for prediction of hepatitis B and hepatitis C seropositivity among Libyan population. Clinical Microbiology and Infection. 2010; 16:S310. doi: http://dx.doi.org/10.1111/j.1469-0691.2010.03239.x PMID: 70195731.
32. Elzouki AN, Beeching NJ, Mutton KJ, Garson JA. Anti-HCV antibodies and HCV RNA in Libyan blood donors. Vox sanguinis. 1995; 68(1):65. Epub 1995/01/01. PMID: 7536992.
33. Elbouaishi A, Rhoma N, Turki M, Fituri O, Elbousaife A, Grera A. Nephrotic syndrome in Libyan children. Jamahiriya Medical Journal. 2010; 10(3):199-205. PMID: 2011019906.
34. Lo BB, Meymouna M, Boulahi MA, Tew M, Sow A, Ba A, et al. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania. [French] Prevalence des marqueurs seriques des virus des hepatites B et C chez les donneurs de sang a Nouakchott, Mauritanie. Bulletin de la Societe de pathologie exotique (1990). 1999; 92(2):83-4. PMID: 10399594.
35. HIV Integrated Behavioral and Biological Surveillance Surveys Morocco 2011-2012. Injecting drug users in Tanger and Nador, Morocco. 2012.
36. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca]. Nephrologie & therapeutique. 2005; 1(5):274-84. Epub 2006/08/10. doi: 10.1016/j.nephro. 2005.06.012 PMID: 16895696.
37. Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, et al. Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. [French] Prevalence des anticorps anti-VHC et incidence de seroconversion dans cinq centres d'hemodialyse au Maroc. Nephrologie et Therapeutique. 2008; 4(2):105-10. doi: http://dx.doi.org/10.1016/j.nephro.2007.11. 007 PMID: 2008175807.
38. Amar Y, Benamar L, Laouad I, Ezaitouni F, Ouzeddoun N, Balafrej L. Hepatitis C virus infection in a Moroccan hemodialysis unit: prevalence and risk factors. [French] L'hepatite virale C dans un centre d'hemodialyse marocain: prevalence et fracturs de risque. Gastroenterologie clinique et biologique. 2005; 29(6-7):746-7. PMID: 16149187.
39. Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A. Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Research in virology. 1996; 147(4):247-55. Epub 1996/07/01. PMID: 8837233.
40. Bousfiha AA, Hachim J, Benjelloun S, Benslimane A, Mikou N, Hadj Khalifa H. Prevalence of infection with the hepatitis B and C viruses and the human immunodeficiency virus in 39 Maroccan children with hemophilia. [French] Prevalence des hepatites virales B et C et du VIH chez 39 enfants hemophiles Marocains. Annales de Pediatrie. 1999; 46(3):199-204. PMID: 1999103898.
41. El Khorassani M, Kababri M, Hessissen L, Khattab M, Kili A. Hemophilia in Morocco: Current state and prospects. Haemophilia. 2010; 16:61. doi: http://dx.doi.org/10.1111/j.1365-2516.2010.02283.x PMID: 70225085.
42. Cacoub P, Ohayon V, Sekkat S, Dumont B, Sbai A, Lunel F, et al. Epidemiologic and virologic study of hepatitis C virus infections in Morocco. [French] Etude epidemiologique et virologique des infections par le virus de l'hepatite C au Maroc. Gastroenterologie clinique et biologique. 2000; 24(2):169-73. PMID: 12687957.
43. Rebbani K, Ouladlahsen A, Bensghir A, Akil A, Lamdini H, Issouf H, et al. Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco. Clinical Microbiology and Infection. 2013; 19(10):E454-E7. doi: http://dx.doi.org/10.1111/1469-0691.12252 PMID: 2013611671.
44. Zahraoui-Mehadji M, Baakrim MZ, Laraqui S, Laraqui O, El Kabouss Y, Verger C, et al. [Infectious risks associated with blood exposure for traditional barbers and their customers in Morocco]. Sante (Montrouge, France). 2004; 14(4):211-6. Epub 2005/03/05. PMID: 15745870.
45. Belbacha I, Cherkaoui I, Akrim M, Dooley KE, El Aouad R. Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco Seroprevalence de l'hepatite B et C chez les barbiers et leurs clients dans la Region de Rabat (Maroc). Eastern Mediterranean Health Journal. 2011; 17(12):911-9. PMID: 2012008203.
46. Lahlou Amine I, Zouhair S, Chegri M, L'Kassmi H. Seroprevalence of anti-HCV in patients of the Military Hospital Moulay Ismail (Meknes, Morocco): Data analysis of the medical biology laboratory (2002-2005). [French] Seroprevalence des anticorps anti-VHC chez les patients de l'hopital militaire Moulay Ismail (Meknes, Maroc): Analyse des donnees du laboratoire de biologie medicale (2002-2005). Bulletin de la Societe de Pathologie Exotique. 2010; 103(4):255-8. doi: http://dx.doi.org/10. 1007/s13149-010-0064-x PMID: 20596810.
47. Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M. Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. [French] Prevalence de l'infection par le virus de l'hepatite-C au Maroc et evaluation des tests serologiques de depistage pour la prediction de la viremie. Pathologie Biologie. 2009; 57(5):368-72. doi: http://dx.doi.org/10. 1016/j.patbio.2008.07.006 PMID: 2009311009.
48. Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC public health. 2013; 13:50. Epub 2013/01/22. doi: 10.1186/1471-2458-13-50 PMID: 23331910; PubMed Central PMCID: PMC3640941.
49. Benani A, Baha W, Dersi N, Ennaji M, Lazaar F, El Malki A, et al. Molecular epidemiology of HCV in Morocco. Clinical Microbiology and Infection. 2011; 17:S658. doi: http://dx.doi.org/10.1111/j.1469-0691.2011.03558.x PMID: 70600878.
50. Aqodad N, Lahbabi M, Elyousfi M, Mellouki I, Benajah D, Elabkari M, et al. Prevalence of VHC-Ab and HBsAg among blood donors in Guelmim in the south of Morocco. Hepatology International. 2011; 5 (1):96. doi: http://dx.doi.org/10.1007/s12072-010-9241-z PMID: 70369163.
51. WHO/EMRO. Regional database on HIV/AIDS. WHO Regional Office for the Eastern Mediterranean. 2006.
52. Zohoun A, Hadef R, Zahid H, Benkirane M. [Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco]. [French] Prevalence des marqueurs seriques des virus de l'hepatite B et C chez les donneurs de sang au Centre de Transfusion Sanguine de l'Hopital Militaire d'Instruction Mohammed V de Rabat (Maroc). Medecine tropicale: revue du Corps de sante colonial. 2011; 71(5):513-4. PMID: 22235634.
53. WHO/EMRO. Regional database on HIV/AIDS. WHO Regional Office for the Eastern Mediterranean. 2011.
54. Rioche M, Himmich H, Cherkaoui A, Mourid A, Dubreuil P, Zahraoui M, et al. High incidence of sporadic non-A, non-B hepatitis in Morocco: epidemiologic study. [French] Forte incidence des hepatites non-A, non-B sporadiques au Maroc: etude epidemiologique. Bulletin de la Societe de pathologie exotique (1990). 1991; 84(2):117-27. PMID: 1655298.
55. Ezzikouri S, El Feydi AE, Afifi R, El Kihal L, Benazzouz M, Hassar M, et al. MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population. Cancer detection and prevention. 2009; 32(5-6):380-5. Epub 2009/02/24. doi: 10.1016/j.cdp.2009. 01.003 PMID: 19233569.
56. Lakhoua Gorgi Y, Gorgi F, Madkouri G, Abderrahim E, Sfar I, Ramadani B, et al. Hepatitis viral C in kidney transplantation: Comparative study between two Maghrebin centers: Casablanca and Tunis. [French] L'hepatite virale C au cours de la transplantation renale: Etude comparative entre deux centres Maghrebins: Casablanca et Tunis. Tunisie Medicale. 2010; 88(12):902-9. PMID: 2011012886.
57. Radoui A, Skalli Z, Haddiya I, Benamar L, Ezzaitouni F, Ouzeddoun N, et al. Prevalence and predictive factors of anemia after renal transplantation: A moroccan report. Transplantation Proceedings. 2010; 42(9):3542-9. doi: http://dx.doi.org/10.1016/j.transproceed.2010.07.092 PMID: 2010651818.
58. Mohammed T, Fatima Zohra L, Ahmed B, Rhimou A. Echographic prevalence of hepatic steatosis in Moroccan hospitalized patients. Hepatology International. 2012; 6 (1):283. doi: http://dx.doi.org/10. 1007/s12072-011-9333-4 PMID: 70812822.
59. Bousfiha AA, Bouchrit M, Abid A, Benslimane A. Children's acute hepatitis in Casablanca. [French] Hepatites virales icteriques aigues de l'enfant a Casablanca. Medecine et Maladies Infectieuses. 1999; 29(12):749-52. doi: http://dx.doi.org/10.1016/S0399-077X%2800%2988284-0 PMID: 2000024417.
60. Ayed K, Gorgi Y, Ben Abdallah T, Aouadi H, Jendoubi-Ayed S, Sfar I, et al. Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods. Transplantation proceedings. 2003; 35(7):2573-5. Epub 2003/11/13. PMID: 14612022.
61. Belarbi A, Ben Ammar H, Moula O, Bouasker A, Ghachem R. Addiction to high dose buprenorphine and sexually transmitted diseases in Tunisia. European Psychiatry. 2013; 28. PMID: 71172692.
62. Bejaoui M, Guirat N. Beta thalassemia major in a developing country: Epidemiological, clinical and evolutionary aspects. Mediterranean Journal of Hematology and Infectious Diseases. 2013; 5(1). doi: http://dx.doi.org/10.4084/MJHID.2013.002 PMID: 2013324627.
63. Hannachi N, Boughammoura L, Marzouk M, Tfifha M, Khlif A, Soussi S, et al. Viral infection risk in polytransfused adults: Seroprevalence of seven viruses in central Tunisia. [French] Le risque infectieux viral chez le polytransfuse: Seroprevalence de sept agents viraux dans le centre tunisien. Bulletin de la Societe de Pathologie Exotique. 2011; 104(3):220-5. doi: http://dx.doi.org/10.1007/s13149-010-0103-7 PMID: 21695497.
64. Tunisie MdlSPe, SIDA ATdLClMel. Enquête sérocomportementale auprès des hommes ayant des rapports sexuels avec des hommes en Tunisie (French) [Biobehavioral survey among men who have sex with men in Tunisia]. Tunis, Tunisia: 2010.
65. Djebbi A, Bahri O, Langar H, Sadraoui A, Mejri S, Triki H. Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs. The new microbiologica. 2008; 31(4):473-80. Epub 2009/ 01/07. PMID: 19123302.
66. Sassi F, Gorgi Y, Ayed K, Abdallah TB, Lamouchi A, Maiz HB. Hepatitis C virus antibodies in dialysis patients in Tunisia: a single center study. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2000; 11(2):218-22. Epub 2008/01/23. PMID: 18209319.
67. Hmida S, Mojaat N, Chaouchi E, Mahjoub T, Khlass B, Abid S, et al. HCV antibodies in hemodialyzed patients in Tunisia. [French] Anticorps anti-HCV chez les hemodialyses en Tunisie. Pathologie-biologie. 1995; 43(7):581-3. PMID: 8570261.
68. Ben Othman S, Bouzgarrou N, Achour A, Bourlet T, Pozzetto B, Trabelsi A. [High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia]. Patholo-gie-biologie. 2004; 52(6):323-7. Epub 2004/07/21. doi: 10.1016/j.patbio.2003.07.001 PMID: 15261374.
69. Hachicha J, Hammami A, Masmoudi H, Ben Hmida M, Karray H, Kharrat M, et al. Hepatitis C virus in haemodialysis patients in the South of Tunisia. Prevalence and risk factors. [French]Hepatite Virale C Chez Les Hemodialyses Chroniques Dans Le Sud Tunisien. Prevalence Et Facteurs De Risque. Annales de Medecine Interne. 1995; 146(5):295-8. PMID: 1995298978.
70. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, et al. Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. Journal of medical virology. 2006; 78(2):185-91. Epub 2005/12/24. doi: 10.1002/jmv.20526 PMID: 16372289.
71. Jemni S, Ikbel K, Kortas M, Mahjoub J, Ghachem L, Bidet JM, et al. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouvelle revue francaise d'hematologie. 1994; 36(5):349-51. Epub 1994/10/01. PMID: 7534398.
72. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, et al. Blood-transmitted viral infections among haemophiliacs in Tunisia. [French] Infections par des virus transmissibles par le sang chez des hemophiles en Tunisie. Transfusion Clinique et Biologique. 2005; 12(4):301-5. doi: http://dx.doi. org/10.1016/j.tracli.2005.07.001 PMID: 2005445805.
73. Kilani B, Ammari L, Marrakchi C, Letaief A, Chakroun M, Ben Jemaa M, et al. Seroepidemiology of HCV-HIV coinfection in Tunisia. La Tunisie medicale. 2007; 85(2):121-3. Epub 2007/08/02. PMID: 17665657.
74. Maaref F, Kilani B, Ammari L, Ben Othman A, Zribi M, Fendri C, et al. Prevalence of hepatitis G, B and C virus infections among positive HIV population in a Tunisian Hospital, La Rabta, Tunis. [French] Prevalence de l'hepatite G et des hepatites virales B et C dans la population VIH (+) de l'hopital La Rabta, Tunis, Tunisie. Pathologie Biologie. 2011; 59(4):213-6. doi: http://dx.doi.org/10.1016/j.patbio. 2009.10.004 PMID: 2011443544.
75. Larabi K, Tourjemene K. Epidemiology of hepatitis C virus infection in the Menzel-Bourguiba region. [French] Epidemiologie de l'infection par le virus de l'hepatite C dans la region de Menzel-Bourguiba. La Tunisie medicale. 2001; 79(12):672-5. PMID: 11892441.
76. Kaabia N, Ben Jazia E, Slim I, Fodha I, Hachfi W, Gaha R, et al. Association of hepatitis C virus infection and diabetes in central Tunisia. World journal of gastroenterology: WJG. 2009; 15(22):2778-81. Epub 2009/06/13. PMID: 19522029; PubMed Central PMCID: PMC2695894.
77. Znazen A, Frikha-Gargouri O, Berrajah L, Bellalouna S, Hakim H, Gueddana N, et al. Sexually transmitted infections among female sex workers in Tunisia: high prevalence of Chlamydia trachomatis. Sexually transmitted infections. 2010; 86(7):500-5. Epub 2010/07/27. doi: 10.1136/sti.2010.042770 PMID: 20656718.
78. Kaabia N, Ben Jazia E, Hannachi N, Khalifa M, Dhouibi S, Dabbabi F, et al. Prevalence of hepatitis C virus among health care workers in central Tunisia. [French]Prevalence de l'hepatite virale C chez le personnel de sante au Centre tunisien. Medecine et Maladies Infectieuses. 2009; 39(1):66-7. doi: http://dx.doi.org/10.1016/j.medmal.2008.10.007 PMID: 2009001047.
79. Coursaget P, Bourdil C, Kastally R, Yvonnet B, Rampanarivo Z, Chiron JP, et al. Prevalence of hepatitis C virus infection in Africa: anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Research in virology. 1990; 141(4):449-54. Epub 1990/07/01. PMID: 1964239.
80. Coursaget P, Leboulleux D, Gharbi Y, Enogat N, Ndao MA, Coll-Seck AM, et al. Etiology of acute sporadic hepatitis in adults in Senegal and Tunisia. Scandinavian journal of infectious diseases. 1995; 27 (1):9-11. Epub 1995/01/01. PMID: 7784826.
81. Krichen C, Rekik H, Feki H, Dammak J, Gargouri J. Prevalence of viral markers among blood donors in Tunisia. Clinical Laboratory. 2001; 47(9-10):509-16. PMID: 2001353914.
82. Mejri S, Ben Salah A, Triki H, Ben Alaya N, Djebbi A, Dellagi K. Contrasting patterns of hepatitis C virus infection in two regions from Tunisia. Journal of Medical Virology. 2005; 76(2):185-93. doi: http://dx.doi.org/10.1002/jmv.20342 PMID: 2005199131.
83. Slama H, Mojaat N, Dahri R, Boukef K. Epidemiologic study of anti-HCV antibodies in Tunisian blood donors. [French] Etude epidemiologique des anticorps anti-HCV chez les donneurs de sang en Tunisie. Revue francaise de transfusion et d'hemobiologie: bulletin de la Societe nationale de transfusion sanguine. 1991; 34(6):459-64. PMID: 1663358.
84. Tunisia Ministry of Health. HIV/AIDS Quarterly Case Notification. 2007.
85. Gorgi Y, Yalaoui S, Ben Nejma HL, Azzouz MM, Hsairi M, Ben Khelifa H, et al. Detection of hepatitis C virus in the general population of Tunisia. [French] Depistage de l'hepatite virale C dans la population generale en Tunisie. Bulletin de la Societe de pathologie exotique (1990). 1998; 91(2):177. PMID: 9642480.
86. Hatira SA, Yacoub-Jemni S, Houissa B, Kaabi H, Zaeir M, Kortas M, et al. Hepatitis C virus antibodies in 34130 blood donors in Tunisian Sahel. [French] Les anti V.H.C chez 34130 donneurs de sang du Sahel Tunisien. La Tunisie medicale. 2000; 78(2):101-5. PMID: 10894044.
87. Health TMo. HIV/AIDS Quarterly Case Notification. 2006.
88. Triki H. Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia. [French] Epidemiologie des virus des hepatites B, C et Delta dans la population generale et les cirrhoses hepatitiques en Tunisie. Archives de l'Institut Pasteur de Tunis. 1994; 71(3-4):403-6. PMID: 8801835.
89. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1997; 91(1):11-4. Epub 1997/01/01. PMID: 9093616.